Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

Clinical trial NCT06691893 · RECRUITING

Trial details

NCT number: NCT06691893
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency (EPI)Pancreatitis

Start date: 2025-03-28
Primary completion: 2027-04-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.